BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Parker Huges Cancer Center Release: Survival Outcomes Beat National Average


10/19/2005 5:12:35 PM

ROSEVILLE, Minn., Jan. 28 /PRNewswire/ -- Parker Hughes Cancer Center oncologists presented two papers with their clinical treatment outcome results for pancreas cancer and colon cancer at the 2005 Gastrointestinal Cancers Symposium co-sponsored by American Society of Clinical Oncology, The Society of Surgical Oncology and American Gastroenterological Association held in Hollywood, Florida, January 27-29, 2005. In advanced metastatic pancreas cancer, the patient-tailored treatments at Parker Hughes Cancer Center guided by fusion imaging, a state-of-the art imaging method which allows doctors to stop ineffective treatments in a timely fashion, were more than 200% better than the national average and thus tripled the survival of patients with otherwise invariably fatal cancer. In metastatic colon cancer, patient- tailored treatments delivered in an outpatient setting resulted in long-term survival of patients.

In addition to these exciting new clinical data, the Center's director, Dr. Fatih Uckun, will give a talk on Saturday, January 29, 2005 regarding a new cancer prevention technology developed at Parker Hughes which prevents polyps from turning into colon cancer. The presentations are posted on Parker Hughes website at http://www.parkerhughes.org/news/index.html .

According to the American Cancer Society there were an estimated 147,000 new cases of colon cancer last year and roughly 57,000 deaths. For pancreas cancer there were an estimated 32,000 new cases and roughly 31,000 deaths.

Reference: 1. Patient-Tailored Outpatient Chemotherapy Regimens For Inoperable Advanced Metastatic Pancreas Cancer. Meeting: 2005 Gastrointestinal Cancers Symposium Abstract No: 89 2. Chemoprevention of Colorectal Cancer By Targeting of Janus Kinase 3 (JAK3). Meeting: 2005 Gastrointestinal Cancers Symposium Abstract No: 161 3. Patient-Tailored Outpatient Chemotherapy Regimens for Metastatic Colorectal Cancer Meeting: 2005 Gastrointestinal Cancers Symposium Abstract No: 176

Parker Hughes Cancer Center

CONTACT: Tom Knisely of Parker Hughes Cancer Center, +1-651-295-2990



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES